BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2479742)

  • 1. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas.
    Vigneswaran N; Peters KP; Hornstein OP; Haneke E
    J Oral Pathol Med; 1989 Aug; 18(7):377-90. PubMed ID: 2479742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical distribution of monoclonal antibodies against keratin in papillomas and carcinomas from oral and nasopharyngeal regions.
    Nakai M; Mori M
    Oral Surg Oral Med Oral Pathol; 1986 Sep; 62(3):292-302. PubMed ID: 2427988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of intermediate filament proteins in benign lesions of the oral mucosa.
    van der Velden LA; Manni JJ; Ramaekers FC; Kuijpers W
    Eur Arch Otorhinolaryngol; 1999; 256(10):514-9. PubMed ID: 10638360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcifying odontogenic cysts: co-expression of intermediate filament proteins, and immunohistochemical distribution of keratins, involucrin, and filaggrin.
    Kakudo K; Mushimoto K; Shirasu R; Kasai T; Yamada K; Mori M
    Pathol Res Pract; 1989 Dec; 185(6):891-9. PubMed ID: 2482484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of cell surface carbohydrates associated with ordered and disordered proliferation of oral epithelia: a lectin histochemical study in oral leukoplakias, papillomas and carcinomas.
    Vigneswaran N; Peters KP; Hornstein OP; Diepgen TL
    Cell Tissue Kinet; 1990 Jan; 23(1):41-55. PubMed ID: 2302731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of filaggrin in preneoplastic and neoplastic lesions of the human oral mucosa.
    Itoiz ME; Conti CJ; Lanfranchi HE; Mamrack M; Klein-Szanto AJ
    Am J Pathol; 1985 Jun; 119(3):456-61. PubMed ID: 4014435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of cytokeratins, involucrin, and blood group antigens in oral squamous cell carcinomas.
    Toto PD; Nadimi H
    Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):75-80. PubMed ID: 1695342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of expression of cytokeratin 19 in different histological grades of leukoplakia and oral squamous cell carcinoma.
    Ram Prassad VV; Nirmala NR; Kotian MS
    Indian J Dent Res; 2005; 16(1):6-11. PubMed ID: 16375229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staining patterns of human pre-malignant oral epithelium and squamous cell carcinomas by monoclonal anti-keratin antibodies.
    Reibel J; Clausen H; Dabelsteen E
    Acta Pathol Microbiol Immunol Scand A; 1985 Nov; 93(6):323-30. PubMed ID: 2418629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
    Jiang Y; Wu Y; Wang F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.
    Smoller BR; Krueger J; McNutt NS; Hsu A
    Mod Pathol; 1990 Mar; 3(2):171-5. PubMed ID: 1691494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma.
    Fillies T; Jogschies M; Kleinheinz J; Brandt B; Joos U; Buerger H
    Oncol Rep; 2007 Sep; 18(3):639-43. PubMed ID: 17671713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of oral cytokeratins. III. SDS-electrophoretic analysis and immunoblotting of cytokeratins in leukoplakias and squamous cell carcinomas of the oral mucosa.
    Ermich T; Schulz J; Raabe G; Schumann D
    Biomed Biochim Acta; 1989; 48(7):393-401. PubMed ID: 2478123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in expression of terminal differentiation markers of keratinocytes during oral carcinogenesis.
    Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
    Pathobiology; 1994; 62(3):127-33. PubMed ID: 7524529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of filaggrin in benign and malignant lesions of the human oral mucosa.
    Grosso M; Lentini M; Bellizi De Marco E; Petracca R; Leoncini P; Carrozza G
    Basic Appl Histochem; 1990; 34(1):51-8. PubMed ID: 2337405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoepidermoid carcinoma of the salivary glands: immunohistochemical distribution of intermediate filament proteins, involucrin and secretory proteins.
    Huang JW; Mori M; Yamada K; Isono K; Ueno K; Shinohara M; Harada T; Oka M
    Anticancer Res; 1992; 12(3):811-20. PubMed ID: 1377895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [S phase fraction and immunohistologic demonstration of the epithelial marker MAM-6 in orofacial tumors].
    Kunz J; Ruschin P; Zotter S
    Zentralbl Allg Pathol; 1986; 132(3):233-42. PubMed ID: 3788316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ha-ras oncogene product in human oral squamous cell carcinoma.
    Oku N; Shimada K; Itoh H
    Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.